| Molecular Formula | C10H7NO4 |
| Molar Mass | 205.17 |
| Density | 1.559±0.06 g/cm3(Predicted) |
| Melting Point | 240 °C |
| Boling Point | 465.6±45.0 °C(Predicted) |
| Appearance | Yellow solid. |
| pKa | 0.81±0.10(Predicted) |
| Storage Condition | Sealed in dry,Store in freezer, under -20°C |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 4.874 ml | 24.37 ml | 48.74 ml |
| 5 mM | 0.975 ml | 4.874 ml | 9.748 ml |
| 10 mM | 0.487 ml | 2.437 ml | 4.874 ml |
| 5 mM | 0.097 ml | 0.487 ml | 0.975 ml |
| biological activity | Tyrphostin AG30 (AG30) is an effective epidermal growth factor receptor protein tyrosine kinase (EGFR tyrosine kinase) inhibitor. Tyrphostin AG30 (AG30) selectively inhibits c-ErbB self-renewal induction and inhibits primary erythrocyte c-ErbB activation of STAT5. |